The European Commission’s green light marks Breyanzi’s fourth indication in Europe and extends access to patients across all EU and EEA countries
The proposed transaction will be effected as a share swap
The Unit is approved by major regulators like EMA, Europe; Health Canada, Anvisa, Brazil and TGA, Australia
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
The company says the innovation delivers stronger moisture protection for highly sensitive drug molecules
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
Subscribe To Our Newsletter & Stay Updated
